Supernus Pharmaceuticals 宣布,Indivior Pharmaceuticals 的股东们将在合并交易正式完成之前,立即获得一笔总额高达10亿美元的一次性特别现金股息。这笔款项将以现金形式发放,旨在合并程序启动前向股东兑现价值。
Supernus Pharmaceuticals 宣布,Indivior Pharmaceuticals 的股东们将在合并交易正式完成之前,立即获得一笔总额高达10亿美元的一次性特别现金股息。这笔款项将以现金形式发放,旨在合并程序启动前向股东兑现价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.